captopril

Objective To improve preparation technology of Captopril Tablets and solve its problem of bad content uniformity.

目的探讨卡托普利片“空白颗粒法”直接压片的最佳制备工艺条件.

CHF treated with captopril can change and have better curative effect.

为了使CHF能够有明显的改变,用卡托普利联合治疗,取得了很好的疗效.

Conclusion Captopril is able to preserve ischemic myocardium.

结论卡托普利对缺血心肌具有保护作用.

The cutaneous reactions were an allergic response to captopril.

皮肤反应是对卡托普利过敏所致.

Objective To evaluate the pharmaceutical effect of angiotensin-converting enzyme inhibitor ( ACEI ) captopril on ischemic myocardium.

目的评价血管紧张素转换酶抑制剂 ( ACEI ) 卡托普利对缺血心肌的药理作用.

Method: 39 patients were treated with losartan and 35 were treated with captopril for 6 months.

方法:分 别对39名高血压病人用科素亚及35名高血压病人用卡托普利治疗6个月.

Objective To observe the effect of captopril and betaloc on chronic congestive heart failure ( CHF ).

目的联用卡托普利及倍他乐克治疗慢性充血性心力衰竭 ( CHF ) 观察疗效.

Conclusion: Captopril may effectively prevent and treat myocardial hypertrophy.

结论: 卡托普利能有效防治心肌肥厚的发生.

Albumin excrete rate AER decreased only in the Captopril Treated groups.

尿微量白蛋白排泄率(AER) 仅Captopril组显著下降.

Results Captopril could inhibit interstitial fibrosis, decrease apoptotic cells and ameliorate ventricular function.

结果卡托普利可抑制CHM组织 间质纤维化 、 减少凋亡细胞、改善心功能.

Objective : article reviews the numerous pharmacological the new therapies in clinic of captopril.

目的 综述卡托普利的多种药理作用,新的临床应用.

Conclusion Captopril enhances the endogenous fibrinolytic system in patients with AMI and UAP.

结论卡托普利增强冠心病患者内源性纤溶系统活性.

Objcetive To investigate the effect and the mechanism of captopril for the treatment of viral myocarditis.

目的探讨卡托普利对病毒性心肌炎疗效及作用机制.

Results The problems of bad content uniformity content of Captopril disulfide in Captopril Tablets were Solved.

结果卡托普利片含量均匀度合格,质量稳定.

This lack of benefit has been commonly overlooked in the interpretation of the captopril trial results.

这一不足通常在解释卡托普利临床试验结果是都被忽略.